Ariceum Therapeutics

EUIPO EUIPO 2022 Trademark registered

Protect this trademark from copycats!

With our trademark monitoring alerts, you are automatically notified by email about copycats and free riders.

The Union trademark Ariceum Therapeutics was filed as Word mark on 02/23/2022 at the European Union Intellectual Property Office.
It was registered as a trademark on 06/18/2022. The current status of the mark is "Trademark registered".

Trademark Details Last update: October 3, 2022

Trademark form Word mark
File reference 018659991
Application date February 23, 2022
Publication date March 11, 2022
Entry date June 18, 2022
Expiration date February 23, 2032

Trademark owner

Robert-Rössle-Straße 10, Haus 79
13125 Berlin
DE

Trademark representatives

Hansastr. 32 80686 Munich DE

goods and services

5 Pharmaceuticals; Pharmaceutical drugs; Pharmaceutical preparations; Injectable pharmaceuticals; Chemico-pharmaceutical preparations; Pharmaceutical preparations and substances; Pharmaceutical preparations for human use; Synthetic peptides for pharmaceutical purposes; Pharmaceutical preparations for medical purposes; Pharmaceutical preparations for the prevention of tumours; Pharmaceutical preparations for the treatment of tumours; Pharmaceutical preparations for the treatment of cancer; Pharmaceutical products for the treatment of cancer; Pharmaceutical preparations and substances for use in oncology; Radioactive substances for medical purposes; Radioactive materials for medical purposes; Radioactive elements for medical use
42 Pharmaceutical products development; Pharmaceutical product evaluation; Testing of pharmaceuticals; Research of pharmaceuticals; Pharmaceutical research and development; Research relating to pharmaceuticals; Conducting clinical trials for pharmaceutical products; Development of pharmaceutical preparations and medicines; Research on the subject of pharmaceuticals; Research and development for the pharmaceutical industry; Research and development in the pharmaceutical and biotechnology fields; Research and development of pharmaceutical preparations for treating malignant tumours; Providing medical and scientific research information in the field of pharmaceuticals and clinical trials; Clinical trials

Trademark history

Date Document number Area Entry
August 2, 2022 Transfer / Change of address, Published

ID: 11018659991